<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04000659</url>
  </required_header>
  <id_info>
    <org_study_id>IDE 1006</org_study_id>
    <nct_id>NCT04000659</nct_id>
  </id_info>
  <brief_title>Episealer® Knee System IDE Clinical Study</brief_title>
  <official_title>A Prospective, Randomized, Controlled, Multi-Center Study to Evaluate the Safety and Effectiveness of the Episealer® Knee System Compared to Microfracture for the Treatment of Focal Femoral Knee Chondral or Osteochondral Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Episurf Medical Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MCRA, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Episurf Medical Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a randomized, prospective, multicenter, controlled clinical trial of the
      Episealer Knee System.The Episealer Knee System is intended for subjects with a focal femoral
      knee chondral or osteochondral lesion that is causing pain and/or disability and requires
      surgical treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objective of this study is to evaluate the safety and clinical effectiveness of
      the Episealer Knee System (Episealer Trochlea Solo, Episealer Femoral Twin, and Episealer
      Condyle Solo) compared to microfracture (with or without debridement) in a group of subjects
      that require repair of a focal femoral chondral or osteochondral lesion in the knee.

      Clinical success will be analyzed via subject reported outcomes to measure function and pain
      improvements as compared to baseline, incidence of secondary surgical interventions for the
      treated knee, absence of subsidence or migration through radiographic assessment, and
      assessment of weight-bearing status.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 18, 2020</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A total of 180 subjects will be enrolled and randomized using a 2:1 ratio (Episealer: Microfracture). Within each site, subjects will be randomized into one of the two study arms using a blocked randomization scheme with varying block sizes.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
    <masking_description>In this investigation, neither the investigator nor the subject can be blinded to the treatment group assignment due to the implant's distinctive form that can be detected on radiographs; however, the randomization assignment will not be disclosed to the subject until after surgery is performed.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the Knee Injury &amp; Osteoarthritis Outcome Score (KOOS) Subscores</measure>
    <time_frame>24 Months</time_frame>
    <description>This endpoint will examine the change in KOOS subscores at 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Visual Analog Scale (VAS) Pain Scores</measure>
    <time_frame>24 Months</time_frame>
    <description>This endpoint will examine the change in VAS Pain scores at 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Secondary Surgical Intervention</measure>
    <time_frame>24 Months</time_frame>
    <description>This endpoint will examine the incidence of Secondary Surgical Interventions (SSIs) at 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of subsidence or migration at 24 months</measure>
    <time_frame>24 Months</time_frame>
    <description>This endpoint will examine the incidence of subsidence/migration at 24 months</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Weight bearing status</measure>
    <time_frame>8 weeks</time_frame>
    <description>This endpoint will examine the weight bearing status at 8 weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in the KOOS Subscores at all follow-up time points</measure>
    <time_frame>3-weeks, 8-weeks, 6-months, 12-months, and 24-months</time_frame>
    <description>This endpoint will examine the change in KOOS subscores at all follow-up time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in VAS Pain score at all follow-up time points</measure>
    <time_frame>3-weeks, 8-weeks, 6-months, 12-months, and 24-months</time_frame>
    <description>This endpoint will examine the change in VAS Pain scores at all follow-up time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 12-Item Short Form Survey (SF-12) score at all follow-up time points</measure>
    <time_frame>3-weeks, 8-weeks, 6-months, 12-months, and 24-months</time_frame>
    <description>This endpoint will examine the change in SF-12 scores at all follow-up time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of radiographic findings at all follow-up time points</measure>
    <time_frame>8 weeks, 12-months, and 24-months</time_frame>
    <description>This endpoint will examine the incidence of radiographic findings at all follow-up time points</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse events and device deficiencies at all follow-up time points</measure>
    <time_frame>3-weeks, 8-weeks, 6-months, 12-months and 24-months</time_frame>
    <description>This endpoint will examine the safety via the incidence of adverse events and device deficiencies at all follow-up time points</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Degenerative Lesion of Articular Cartilage of Knee</condition>
  <arm_group>
    <arm_group_label>Episealer Knee System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental arm will comprise of subjects that will be treated with the Episealer Knee System.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microfracture</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The control arm will comprise of subjects that will receive a Microfracture surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Episealer Knee System</intervention_name>
    <description>The Episealer Knee System is comprised of individualized endoprosthetic resurfacing implants and implantation tools (Episealer Toolkit). The implants are designed to replace the articulating surface which has been damaged due to femoral knee chondral and osteochondral defects.</description>
    <arm_group_label>Episealer Knee System</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microfracture</intervention_name>
    <description>Microfracture is a minimally invasive surgical technique developed to repair defects in articular cartilage and reduce pain in the knee joint. Microfracture techniques are described in the orthopedic literature and are performed arthroscopically.</description>
    <arm_group_label>Microfracture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA:

          -  Age between 30 and 70 years

          -  Have a single articular cartilage lesion in the femoral condyle or trochlea area

          -  Have undergone prior non-surgical management in the index knee

        EXCLUSION CRITERIA:

          -  Have a BMI greater than 35 kg/m2

          -  Have undergone prior surgical treatment for the cartilage defect

          -  Have an existing knee prosthesis in the index knee

          -  Have a bone disease that impacts bone quality

          -  Have rheumatoid arthritis

          -  Have a known immunodeficiency

          -  Have known allergies to Cobalt-Chrome alloy or Titanium

          -  Have any contraindication to MRI

          -  Any condition, therapy or medication that would interfere with healing or the
             evaluation of outcome measures
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katarina Flodström</last_name>
    <role>Study Director</role>
    <affiliation>Episurf Medical Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Katarina Flodström</last_name>
    <phone>1 686 845 9447</phone>
    <email>Katarina.Flodstrom@episurf.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Orthopaedic Research Foundation, Inc.</name>
      <address>
        <city>Greenwood</city>
        <state>Indiana</state>
        <zip>46142</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vicki Snodgrass Miller</last_name>
      <phone>317-884-5230</phone>
      <email>vsmiller@orthoindy.com</email>
    </contact>
    <investigator>
      <last_name>Jack Farr, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Plancher Orthopaedics &amp; Sports Medicine</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10128</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Petterson</last_name>
      <phone>203-869-2002</phone>
      <email>spetterson@ofals.org</email>
    </contact>
    <investigator>
      <last_name>Kevin Plancher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Research Solutions</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amy Arnold</last_name>
      <phone>731-431-5027</phone>
      <email>aarnold@crssites.com</email>
    </contact>
    <investigator>
      <last_name>Jason Hutchison, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Idrætsklinikken, Aarhus Universitetshospital</name>
      <address>
        <city>Aarhus N</city>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Torsten Grønbech Nielsen</last_name>
      <phone>+45 40491184</phone>
      <email>torsten.gronbech.nielsen@auh.rm.dk</email>
    </contact>
    <investigator>
      <last_name>Martin Lind, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitatsmedizin Berlin Charite</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Derya Belkacem</last_name>
      <phone>030/450 615 196</phone>
      <email>derya.belkacem@charite.de</email>
    </contact>
    <contact_backup>
      <last_name>Anne Zergiebel</last_name>
      <phone>030/450 515 235</phone>
      <email>anne.zergiebel@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Tobias Jung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Orthocentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <zip>20149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rene Kaiser</last_name>
      <phone>+4940443639</phone>
      <email>kaiser@oc-h.de</email>
    </contact>
    <investigator>
      <last_name>Johannes Holt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Germany</country>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 10, 2019</study_first_submitted>
  <study_first_submitted_qc>June 25, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 27, 2019</study_first_posted>
  <last_update_submitted>July 23, 2020</last_update_submitted>
  <last_update_submitted_qc>July 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee</keyword>
  <keyword>Cartilage</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

